RYOIX
Rydex Biotechnology Fund Class Investor [RYOIX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RYOIX Stock Summary
Top RYOIX Correlated Resources
RYOIX
Top 10 Correlated ETFs
RYOIX
Top 10 Correlated Stocks
RYOIX
In the News
RYOIX Financial details
Company Rating
-
Market Cap
107.05M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
6.21%
SMA50
12.2%
SMA100
21.56%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
61.03-77.53
52W High
-7.29%
52W Low
+17.03%
RSI
58.07
Rel Volume
-
Avg Volume
-
Volume
Perf Week
-0.1%
Perf Month
7.94%
Perf Quarter
6.62%
Perf Half Y
6.71%
-
-
-
-
Beta
0.78
-
-
Volatility
0.57%, 1.95%
Prev Close
-1.63%
Price
71.39
Change
-1.63%
Company Profile
- Market Capitalization 107.05M
- Headquarters US
- IPO Date 1998-03-31
The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
